Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Working Capital Changes (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Other Working Capital Changes for 7 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 28.38% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, down 41.15% year-over-year, with the annual reading at $2.0 million for FY2025, 41.15% down from the prior year.
  • Other Working Capital Changes hit $2.5 million in Q4 2025 for Eton Pharmaceuticals, up from $122000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $3.5 million in Q4 2024 to a low of -$3.0 million in Q1 2025.
  • Historically, Other Working Capital Changes has averaged $220600.0 across 5 years, with a median of $21500.0 in 2024.
  • Biggest five-year swings in Other Working Capital Changes: skyrocketed 1400.0% in 2021 and later plummeted 3663.29% in 2025.
  • Year by year, Other Working Capital Changes stood at $743000.0 in 2021, then tumbled by 61.1% to $289000.0 in 2022, then surged by 126.64% to $655000.0 in 2023, then skyrocketed by 437.4% to $3.5 million in 2024, then fell by 28.38% to $2.5 million in 2025.
  • Business Quant data shows Other Working Capital Changes for ETON at $2.5 million in Q4 2025, $122000.0 in Q3 2025, and $2.3 million in Q2 2025.